Friday, March 11, 2016

Assessing Aduro's Prospects In Cancer Immunotherapy

… patients with historically deadly tumors like squamous lung cancer and metastatic melanoma … the tumors being targeted. Advaxis is targeting head and neck tumors, prostate cancer, and HER2-positive breast cancer.
Another potential downside …

No comments:

Post a Comment